Concepedia

Snehal Naik

SN

Statistics

Publications

21

Citations

1.5K

H-Index

20

Active since

1997

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of California San Diego

Mallinckrodt (United States)

KU Leuven

Imaging Center

Snehal Naik is an author at Icahn School of Medicine at Mount Sinai specializing in life sciences, pharmacology, and inflammatory bowel disease.

Publications per year

1997–2025

21

Publications

21

Pharmacological Activation of Liver X Receptors Promotes Reverse Cholesterol Transport In Vivo

Snehal Naik, Xun Wang, Da Silva et al. · Circulation · 2005 · 378 citations

, , +17

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis

William J. Sandborn, Laurent Peyrin‐Biroulet, Jinkun Zhang et al. · Gastroenterology · 2019 · 226 citations · Full text

, , +17

Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study

Séverine Vermeire, Michael Chiorean, Julián Panés et al. · Journal of Crohn s and Colitis · 2021 · 103 citations · Full text

, , +14

Dual-Color Click Beetle Luciferase Heteroprotein Fragment Complementation Assays

Víctor M. Villalobos, Snehal Naik, Monique W. Bruinsma et al. · Chemistry & Biology · 2010 · 74 citations

, , +7

Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant β-Catenin Activation in Colon Cancer

Snehal Naik, Robin S. Dothager, Jayne Marasa et al. · Clinical Cancer Research · 2009 · 69 citations

, , +17

1–5 of 21